Article

New task force to tackle wrong site, wrong IOL surgery as first initiative

San Fransisco-A new task force has been formed by the American Academy of Ophthalmology (AAO).

San Fransisco-A new task force that will focus on physician competency, patient care, and safety, the Performance Improvement Taskforce, has been formed by the American Academy of Ophthalmology (AAO) with the assistance of the American Board of Ophthalmology (ABO) and the Ophthalmic Mutual Insurance Co..

The task force will create education-related activities and tools to help physicians identify and measure areas of improvement using evidence-based and common-sense protocols. The first mission of the task force is to address IOL implant surgery performed on the wrong eye or with the wrong IOL. Of the 106 cases covering 23 years studied, such mistakes were the most common ones made by physicians and their teams, according to a retrospective study in the Archives of Ophthalmology that documents surgical confusion.

"Mistakes are extremely uncommon when it comes to wrong site or wrong IOL implant, but they are serious," said Joseph Caprioli, MD, FACS, chairman of the task force and professor of ophthalmology at the Jules Stein Eye Institute of the University of California, Los Angeles. "Simple steps that begin in the office and end in the operating room can help ophthalmologists eliminate rare occurrences of serious mistakes."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.